HIGHLIGHTS
BOK mRNA is destabilized by AU-(mouse) or U-rich (human) elements within its 3' UTR Mutation of these ARE/ URE sequences results in increased BOK RNA and protein levels TRIM28 represses BOK expression by associating with the UREs of human BOK mRNA Inverse correlation of TRIM28 and BOK levels predicts survival in selected cancers
INTRODUCTION
The abundance of a protein results from the interplay of epigenetic, (post-)transcriptional, and (post-)translational events. The post-transcriptional control of gene expression is based on the recruitment of RNAbinding proteins (RBP) (Glisovic et al., 2008) to homing sequences on the target messenger RNA (mRNA) via RNA-recognition motifs (Lunde et al., 2007) . Prominent mechanisms in that respect include micro RNA (miRNA) (Biggar and Storey, 2015) and AU-, U-or GU-rich elements mediating RNA decay (Vlasova-St Louis and Bohjanen, 2014 ).
Contrary to miRNA-based regulation, AU-rich element (ARE)-based mechanisms do not require annealing of complementary RNA strands but a direct recruitment of RBP to the target transcript. These elements are preferentially localized in the 3 0 untranslated region (3' UTR) of the mRNA. Initially, this mechanism was described only for the pentamer AUUUA, whereas later experimental evidence revealed that extended variants reaching up to 13-mers, as well as GU-and U-rich sequence patterns, were likewise able to modulate the half-life of transcripts (Fallmann et al., 2016) . Moreover, the impact of these elements on mRNA stability is determined by the nature of the recruited RBP, which can be grouped into mRNA stabilizers, such as ELAVL1 (Wigington et al., 2015) , NCL (Sengupta et al., 2004) , and ZMAT3 (Vilborg et al., 2009) , or mRNA destabilizing members, such as HNRNPD (Ishimaru et al., 2010) and ZFP36 (Murata et al., 2005) .
Although ARE-mediated mRNA modulation is known to influence the landscape of gene expression (Bakheet et al., 2018) , its impact on members of the BCL-2 family, which are key regulators of the intrinsic (mitochondrial) apoptotic pathway, is poorly understood, with the notable exception of BCL-2 itself. The expression of BCL-2 has been shown to be influenced by the balance of HNRNPD and NCL recruited to the 3' UTR of its transcript, with implications for the integrity of the mouse B cell compartment upon deletion of critical AREs therein (Diaz-Munoz et al., 2015; Schiavone et al., 2000) .
BCL-2-related ovarian killer (BOK) is a member of the BCL-2 family closely related to the pro-apoptotic multi-BH-domain containing members BAX and BAK Ke et al., 2018; Zheng et al., 2018) . Although BOK has a particularly high affinity for the ER and associated membranes, its enforced accumulation or overexpression leads to intrinsic apoptosis, suggesting that cellular BOK levels need to be tightly regulated in healthy cells (Echeverry et al., 2013; Llambi et al., 2016; Rabachini et al., 2017) . Interestingly, there are indications of selective loss of BOK in cancer, as the genomic locus containing the human BOK gene is deleted in a substantial percentage (average 15%) of human cancers (Beroukhim et al., 2010) . We recently showed that BOK is downregulated in patients with late stage (lymph node positive) versus early stage non-small cell lung cancer (NSCLC), with high BOK protein levels being predictive of extended patient survival (Moravcikova et al., 2017) . Likewise, BOK was shown to be downregulated and of prognostic value in colorectal carcinoma (Carberry et al., 2018) . Current understanding of the mechanism(s) regulating these changes in BOK abundance is meagre, restricted to epigenetic regulation by promoter methylation (Moravcikova et al., 2017) or selective proteasomal turnover, which seems to be linked to the localization of BOK at the ER and regulated by the ERAD pathway and the interaction of BOK with inositol triphosphate receptors (Llambi et al., 2016; Schulman et al., 2013 Schulman et al., , 2016 .
Tripartite Motif Containing 28 (TRIM28/TIF1-b/KAP1) is a co-repressor multidomain protein acting together with Krü ppel-Associated Box Zinc Finger Protein (KRAB-ZNF) transcription factors (Friedman et al., 1996; Moosmann et al., 1996) , nucleosome remodeling deacetylase (NuRD), and heterochromatinassociated protein 1 (HP1) (Cheng et al., 2014) to silence multiple genes at the chromatin level. These interactions sustain the role of TRIM28 as a regulatory hub in multiple processes such as the maintenance of cell stemness (Hu et al., 2009) , inhibition of p53 activity (Okamoto et al., 2006) , transcriptional repression (Groner et al., 2010) , and epithelial-mesenchymal transition (EMT) (Venkov et al., 2007) . Interestingly, despite its key role in regulating chromatin activity (Alexander et al., 2015) and direct gene transcription (Bunch et al., 2014) , TRIM28 lacks obvious DNA-binding domains and thus depends on adaptor proteins to localize to the DNA (Iyengar and Farnham, 2011) . The functional pleiotropism of TRIM28 has been linked to tumorigenesis, and studies with human cancer cell lines or xenografts highlight the contribution of TRIM28 to sustained mTOR activation and cell cycle progression (Li et al., 2018) , sustained Warburg effect (Jin et al., 2017) , and maintenance of the cancer stem cell niche (Czerwinska et al., 2017) . Moreover, from a clinical perspective, TRIM28 has been reported to be overexpressed in cervical (Li et al., 2018) , hepatocellular (Jin et al., 2017) , breast (Czerwinska et al., 2017) , and ovarian (Cui et al., 2014) cancers, in all of which it is associated with a poor clinical prognosis.
Here, we describe a regulatory circuit controlling BOK expression at the transcript level, involving conserved (AU/U)-rich elements (ARE/URE) present in the 3' UTRs of both human and mouse BOK mRNA. Remarkably, negative regulation of human BOK expression through mRNA destabilization depends on the unexpected association of TRIM28 with these URE sites. Furthermore, TRIM28-dependent repression specifically targets BOK, whereas it does not affect the pro-apoptotic multidomain BCL-2 family members BAX and BAK. This TRIM28-mediated negative regulation of BOK might have important clinical implications since TRIM28 high BOK low levels were associated with poor patient survival in certain cancer (sub-)types.
RESULTS
The 3 0 Untranslated Region of Mouse Bok mRNA Contains a Strong Negative-Regulating AU-Rich Element
We noticed that the architecture of the mouse Bok mRNA dramatically influences protein expression levels upon transient transfection into the human embryonic kidney cell line HEK293T, which expresses barely detectable levels of endogenous BOK. To further study this phenomenon, we generated a series of expression constructs consisting of the Bok coding sequence (CDS) harboring permutations of the 5 0 and 3 0 UTR or truncated versions of the latter ( Figure 1A ). Although transfection of Bok CDS (or FLAGtagged Bok CDS) resulted in strong protein expression, it was barely detectable when Bok cDNA was used ( Figure 1B ). This was an indication for the presence of one or more negative regulatory elements in either the 5' and/or the 3' UTR of Bok mRNA. As depicted in Figure 1C , the expression of Bok CDS containing either the 3' UTR or the 5' UTR demonstrated that it is the 3' UTR that is responsible for the observed repression.
To map the position of the regulatory sequence(s) present in the 3' UTR, we generated three deletion mutants of the mouse Bok CDS-3'UTR construct, in which similarly sized parts within the 3' UTR were removed (3' UTRD1, 183 bp; 3' UTRD2, 207 bp; and 3' UTRD3, 234 bp) ( Figure 1A ). Co-transfection of these mutants (together with pcDNA3/EGFP at a ratio of 1:10 for normalization of transfection efficiencies) into HEK293T cells and subsequent analyses by qPCR and western blotting demonstrated that region 1 (most proximal to the stop codon) contained all of the negative regulatory element(s) ( Figure 1D ). Furthermore, the concordance observed in Figure 1D (right panel) between transcript and protein levels indicated that the negative regulatory element likely affects Bok mRNA stability, resulting in its degradation. (A-E) (A) List of constructs generated to narrow down the region containing destabilizing elements in the mouse Bok transcript sequence. Western blot analysis of BOK levels in total protein extracts prepared from HEK293T cells transiently transfected with (B) Bok cDNA or Bok CDS (with or without N-terminal FLAG tag), (C) Bok CDS with or without its 5' UTR and/or 3' UTR, (D) Bok CDS combined with the full length or truncated version of its 3' UTR, or (E) Bok CDS combined with its wild-type 3' UTR or harboring discrete point mutations in a predicted AU-rich element (ARE) therein. Each immunoblot is representative of at least three independent experiments. Tubulin and/or EGFP were used to normalize the transfection efficiency and gel loading. The double band detected for BOK corresponds to the full-length protein and a shorter version translated from a cryptic start codon at methionine 15 (Schulman et al., 2016) . Bar graphs to the right of panels D and E show the quantification of BOK levels from quantitative immunoblots (using near-infrared fluorochromes) and real-time quantitative PCR. The data are presented as mean G SD, N = 3. Statistical analysis was performed using a one-way ANOVA followed by a Tukey post-hoc test in GraphPad Prism. Significance levels, p > 0.05 ns , p < 0.01**,
We next made use of the AREsite2 prediction tool (http://nibiru.tbi.univie.ac.at/AREsite2/) (Fallmann et al., 2016) to identify regulatory elements in the mouse Bok 3' UTR and found one sequence corresponding to an ARE located within the 3' UTR region 1 (position 1,049-1,053, sequence AUUUA) ( Figure 1A ). As shown in Figure 1E , site-directed mutagenesis of this ARE site (AUUUA -> GACGU) restored both Bok mRNA and protein expression to levels comparable with expression of the CDS alone. Taken together, these data demonstrate that a single ARE site within the proximal region of the 3' UTR strongly compromises mouse Bok mRNA stability, resulting in decreased protein expression.
The Mouse Bok ARE Sequence Suppresses the Expression of Unrelated Coding Sequences
Considering that the initial experiments were performed with mouse Bok expression constructs in a human cell line we next wanted to confirm our findings in an autologous cell model, namely, SV40 immortalized Bok -/-mouse embryonic fibroblasts (MEF) (Echeverry et al., 2013) . Similar to HEK293T cells, transfection of the mouse Bok CDS into Bok -/-MEFs resulted in a strong protein signal by western blotting, whereas it was barely detectable when the entire cDNA was transfected ( Figure 2A Statistical analysis was performed using a one-way ANOVA followed by a Tukey post-hoc test in GraphPad Prism. Significance levels, p < 0.0001****.
ARE-mediated regulatory mechanism is functional in both human and mouse cells (Figure 2A ). qPCR analysis confirmed that BOK protein levels correlated with mRNA levels (Figure 2A ).
The previous results supported the existence of a conserved regulation of Bok expression through its 3' UTR. We next tested whether the 3' UTR could also modulate unrelated coding sequences. To this purpose, we evaluated the expression of enhanced green fluorescent protein (EGFP) flanked by the 5 0 and 3 0 UTRs of mouse Bok, with or without mutation of the ARE site. In line with our previous results, the inclusion of the Bok 3' UTR massively reduced EGFP expression in both HEK293T and Bok À/À SV40 MEF, whereas the ARE mutation led to a significant rescue of EGFP levels ( Figures 2B and 2C ). These data indicate that the ARE sequence in the mouse Bok 3' UTR is a genuine repressor of gene expression irrespective of the upstream coding sequence.
The Human BOK 3' UTR Contains U-Rich Regulatory Elements
Despite similar exon-intron organization of the mouse and human BOK genes, a remarkable difference resides in the lengths of their respective 3' UTRs, with the human 3' UTR being three times longer than its mouse counterpart; nevertheless, human BOK expression was also found to be strongly repressed by its 3' UTR ( Figure 3A ). Using in silicio tools described earlier, we screened for the existence of ARE sites in the human BOK 3' UTR, also including related GU/CU-and U-rich elements in the analysis. Contrary to the mouse transcript, the human 3' UTR lacks classical ARE sites (core sequence AUUUA) but contains six stretches of non-canonical U-rich elements (five URE, motifs W 1À2 UUUW 1À2 , and one AWTAAA motif, W=U/A) ( Figure S1 ). These six sequences overlapped to some degree and could be reduced to three potential U-rich elements we termed URE1, 2 and 3, respectively ( Figure 3B ). Site-directed mutagenesis of these sites showed that individual destruction of either URE1 or 2 partially recovered BOK mRNA and protein expression, whereas mutation of URE3 did not show any effect ( Figure 3C ). However, simultaneous mutation of URE1 and 2, or of all three URE sites (URE1-3), significantly recovered BOK expression to levels approaching those seen for the transfection control with the CDS ( Figure 3C ). These results indicate that the 3' UTR-dependent negative regulation of BOK is conserved between mice and humans. Furthermore, similar to the single destabilizing ARE site in the mouse Bok transcript, there are two U-rich elements (URE1 and 2) present in the human BOK 3' UTR exerting a comparable regulatory role.
Identification of URE-Binding Proteins in the 3' UTR of Human BOK by Proteomics Approaches
To identify proteins binding to the URE elements within the human BOK 3' UTR and being critical for its repression, we performed a protein pull-down from HEK293T-derived cell lysate using synthetic biotinylated RNA probes encoding human BOK CDS bearing the wild-type or the URE mutated (UREmut1-3) version of the 3' UTR, followed by identification by mass spectrometry. Initial analysis using silver staining on SDS-PAGE-separated samples already indicated differences in the protein binding to each probe compared with the beads-only negative control ( Figure 4A ). Overall, 749 hits were identified, of which 246 (33%) were unique to at least one of the three studied samples ( Figure 4B and Table S1 ). A total of 101 hits were overrepresented more than 1.5 times in the samples pulled down with the wild-type probe compared with the UREmut1-3 probe ( Figure 4B ). Additional filtering criteria using adjusted p values and false discovery rate led to a final list of 84 candidates that were clustered in three major categories according to the differential abundance among the probes and the background ( Figure 4C ). Of particular interest were the resulting hits in clusters 1 and 3, as they displayed the most dramatic differences between wildtype and UREmut1-3 probes; thus, candidates from these clusters were selected for the validation round. Furthermore, we performed an overrepresentation gene ontology test with the selected 106 candidates ( Figure 4D ) and found a significant enrichment in proteins involved in biological processes related to RNA metabolism, processing, and splicing. This group contained several proteins known to assemble into (macro)molecular complexes, which, surprisingly, are not only restricted to the above-mentioned splicing and mRNA 3'-end processing pathways, but also involved in DNA fragmentation during apoptosis, according to the annotation of the Reactome Pathway database (Fabregat et al., 2018) .
TRIM28 Negatively Regulates Human BOK Expression through Association with 3' UTR Contained U-Rich Elements
To validate URE-binding candidates for their role in destabilizing BOK mRNA in living cells, we performed transfections of pooled endoribonuclease-prepared short interfering RNAs (esiRNA) in HEK293T cells stably expressing either the human BOK CDS-3'UTR or its URE mutated version (UREmut1-3). We evaluated several candidates belonging to the clusters defined in Figure 4C (TRIM28, LSM5, SAFB2) as well as one hit (TIAL1) that fell below the selection threshold (p value % 0.05, fold change 3' UTR/3' UTR UREmut1-3 R 1.5) but is a known regulator of mRNA stability, which served as a negative control (Wigington et al., 2015; Zhao et al., 2014) .
From this validation round, only knockdown of TRIM28 produced a robust and statistically significant recovery of BOK protein levels in cells expressing exogenous BOK fused to the wild-type 3' UTR but not the URE1-3 mutated version ( Figure 5A ). TRIM28, also known as KAP1/TIF1-b, is a known co-repressor of gene expression at the chromatin level (Hosoya et al., 2013) . To strengthen our finding of TRIM28 acting at the mRNA level rather than at the genomic BOK locus, we transiently co-transfected TRIM28-specific esiRNA with BOK-3'UTR or BOK-3'UTR(UREmut1-3) expression plasmids into HEK293T cells and confirmed that the knockdown of TRIM28 only rescued BOK expression in those cells receiving the BOK-3'UTR construct, up to 70% compared with the control BOK-3'UTR(UREmut1-3) ( Figure 5B ). Furthermore, we corroborated the presence of endogenous TRIM28 protein in pull-down fractions from lysates prepared from the human cell lines HEK293T, HCT-116, and NCI-H1299 using biotinylated CDS-3'UTR RNA probe. However, the signal was reduced to non-specific binding (comparable with beads-only control) when using (B) List of constructs generated used to validate the functionality of the predicted U-rich destabilizing elements (URE) within the human BOK transcript sequence (see also Figure S1 ). (C) Representative immunoblot showing BOK levels in HEK293T cells transiently transfected with the indicated human BOK expression constructs. The right panel shows the levels of BOK obtained from quantitative immunoblotting using near-infrared fluorochromes and real-time quantitative PCR quantification from three independent experiments. The data are presented as mean G SD, N = 3. Statistical analysis was performed using a one-way ANOVA followed by a Tukey post-hoc test in GraphPad Prism. Significance levels, p > 0.05 ns , p < 0.05*, p < 0.01**, p < 0.001***. the CDS-3'UTR(UREmut1-3) probe, strengthening the evidence that TRIM28 indeed binds to the UREs present in the 3' UTR of BOK (see Figures 5C and S2 for predicted RNA-binding motifs in TRIM28).
This functional link between BOK repression and TRIM28 could further be demonstrated by performing the opposite approach, in which we transiently overexpressed TRIM28 in the BOK-proficient colorectal cancer cell line HCT-116 or the NSCLC cell line NCI-H1299. As shown in Figure 5D , overexpression of HA-tagged TRIM28 resulted in a significant reduction of >50% of endogenous BOK protein levels compared with the control vector. This modulation of endogenous BOK expression was independently confirmed in NCI-H1299 and LXF-289 lung cancer cell lines stably transduced with HA-TRIM28 ( Figures 5E, S3B , and S3C). Of note, this functional association with TRIM28 was specific for BOK within the pro-apoptotic multidomain family members, since the expression levels of BAX and BAK remained unchanged under the same experimental conditions ( Figure 5D ). Given the high level of homology between human and mouse TRIM28, we transfected human TRIM28 into MEF and likewise found reduction in endogenous (mouse) BOK protein levels, supporting a similar mode of action of TRIM28-mediated BOK repression in mouse cells ( Figure S3A ). Taken together, these data demonstrate that TRIM28 recruitment to URE sites in the 3' UTR of human BOK mRNA results in a potent repression of BOK cellular abundance.
BOK and TRIM28 are Negatively Correlated in Selected Types of Cancer
Our previous results demonstrated a negative impact of TRIM28 levels on BOK expression. We next sought to address whether this phenomenon could be detected in the publicly available Cancer Genome Atlas (TCGA) database. As previously reported, we found that elevated transcript levels of TRIM28 constitute a risk factor in several cancer types, whereas BOK transcript levels mostly show an opposite trend (i.e., decreased in cancer), with the notable exception of adrenocortical cancer and skin cutaneous melanoma ( Figures S4 and S5 ). Simultaneous modeling of BOK and TRIM28 levels using multiparametric Cox hazard ratio models in primary tumors derived from patients with kidney clear cell or papillary cell carcinoma as well as hepatocellular carcinoma indicated a significant reduction in the risk of death for patients with elevated BOK levels, which contrasts with the increased risk of death associated with high TRIM28 expression ( Figure 6A ). Supporting these models, patients who simultaneously had BOK levels above and TRIM28 levels below their respective population medians exhibited the best survival rate, in stark contrast to those patients belonging to the opposite strata ( Figure 6B see Table S2 ). Interestingly, in kidney malignancies, TRIM28 and BOK expressions are negatively correlated in the patient stratum with the highest mortality rate, whereas it is less clear for liver and lung carcinomas ( Figure 6C see Table S2 ). Overall, these data strengthen the interrelationship between TRIM28 and BOK expression indicating that, in these selected cancers, the negative correlation between TRIM28 and BOK may potentially be of prognostic clinical value.
DISCUSSION
BOK is emerging as a BCL-2 family member of increasing interest, both during development as well as in its role as a potential tumor suppressor or modulator of cancer behavior (Carberry et al., 2018; Ke et al., 2018; Moravcikova et al., 2017; Rabachini et al., 2017) . Owing to the pro-apoptotic response resulting from its accumulation, BOK expression seems to be tightly regulated at various levels. Here we expand this complexity by describing the existence of AU-and U-rich elements (ARE/URE) within the 3' UTR of mouse or human BOK mRNAs, respectively, both of which contribute to the negative regulation of BOK expression.
Our model provides an alternative yet non-excluding explanation to the previously described epigenetic and proteasomal regulation of BOK levels (Llambi et al., 2016; Moravcikova et al., 2017) . The existence of (A/U)RE could uncouple the transcription rate of the BOK genomic locus from its total protein concentration, explaining previously observed inconsistent correlations between BOK protein and mRNA levels in some mouse tissues and NSCLC biopsies ( HEK293T cells stably expressing human BOK constructs CDS-3'UTR or CDS-3'UTR(UREmut1-3) were transfected with validated esiRNAs targeting the candidates LSM5, TRIM28, SAFB2, and TIAL1. The recovery of BOK protein levels was used to determine involvement of a candidate in the URE-mediated repression of BOK. Immunoblots shown are representative of three independent experiments, and the quantification (right panel) of the signal is presented as mean G SD. Statistical differences were determined using a one-way ANOVA followed by a Tukey post-hoc test.
(B) BOK recovery in HEK293T cells transiently co-transfected with human BOK CDS-3'UTR and esiRNA targeting TRIM28. The 3'UTR(UREmut1-3) construct was used as a 100% reference.
(C) Demonstration of the specific recruitment of endogenous TRIM28 to the 3' UTR of human BOK in three independent cell lines using the indicated biotinylated synthetic probes (see Figure S2 for prediction of RNA binding motifs in TRIM28).
(D) Transient overexpression of HA-tagged TRIM28 in the lung cancer cell line NCI-H1299 or the colon carcinoma cell line HCT-116 leads to downregulation of endogenous BOK without impacting on the levels of BAX or BAK. Quantitative immunoblots are representative of three independent experiments; data are presented as mean G SD. Statistical
In our experimental setting, the (A/U)RE elements in the mouse and human BOK 3' UTRs exclusively acted as a negative regulators, which even worked for unrelated coding sequences, contrasting with the dual role of ARE sequences in both stabilization and destabilization of the mRNA of other genes, such as BCL-2 (Diaz-Munoz et al., 2015; Schiavone et al., 2000) . This dominance of the BOK 3' UTR to suppress its transcript abundance and protein expression also suggests that the post-transcriptional control of BOK may dominate over its translational regulation, e.g. ribosome scanning or cap-(in)dependent translation, which is traditionally exerted by the 5' UTR region (Leppek et al., 2018) .
In human cells, we showed that 3' UTR-dependent repression of BOK involves the recruitment of TRIM28 to the URE elements. This is a striking observation since all known repressing activities of TRIM28 occur at the chromatin level (Bunch et al., 2014; Li et al., 2017) , and more importantly, TRIM28 lacks classical nucleicacid-binding motifs (Iyengar and Farnham, 2011) . Considering this, TRIM28 is likely recruited as part of a multiprotein complex to the 3' UTR-URE sites rather than directly binding to the RNA. However, the latter possibility warrants further investigation since analysis of TRIM28 amino acid sequence with the Web tool catRAPIDsignature (Livi et al., 2016 ) predicts multiple modules with potential RNA-binding activity ( Figure S2 ). Furthermore, experimental evidence from the Landthaler group, characterizing the transcript-bound proteome in HEK293T cells, detected TRIM28 in two of three mass spectrometry runs (Baltz et al., 2012) , supporting the possibility of true mRNA binding of TRIM28. Regarding the underlying mechanism of mRNA degradation, it will be interesting to investigate whether TRIM28 requires its SUMO E3 ligase activity or not. Involvement of E3 ligase activity in such a context has been described for other RNA-binding E3 ligases, such as MEX-3C, which mediates a RING-dependent destabilization of MHC-I transcripts (Cano et al., 2012) .
The repression of BOK in human cells was TRIM28 dependent as demonstrated both by RNA interference and overexpression of TRIM28 in several independent cell lines. This mechanism seems peculiar for BOK, since our mass spectrometry data showed absence of ELAVL1 and tristetraprolin (TTP), two of the most common mediators of ARE-based RNA decay in the human transcriptome (Bakheet et al., 2018) . Another feature of TRIM28-mediated regulation seems to be the specificity for BOK over its pro-apoptotic multidomain relatives BAX and BAK. This might result from the type, abundance, and position of the predicted URE sites in the respective 3' UTRs of these particular genes, which at the same time greatly diverges from the best studied ARE-regulated protein of the whole family, the BCL-2 gene ( Figure S1 ).
Our proteomic approach combined with independent protein pull-downs using biotinylated RNA probes undoubtedly placed TRIM28 at the mRNA level; separating its known role at the chromatin from our discovered function at the mRNA level was challenging. Therefore, we performed our assays using transient transfections and collecting the samples within a short temporal window, as well as included some assays using stable transfections. These assays indicated that relatively high levels of TRIM28 may be required to repress BOK mRNA. It is further possible that TRIM28 may affect BOK protein stability directly (e.g., in LFX-289 cells), and further investigation in that direction is needed. The transient approach allowed us to minimize the likelihood of chromosomal integration of the transfected BOK expression constructs, increasing the chance of a transcript-based regulatory mechanism.
Our results provide a potential value of the TRIM28-dependent, URE-mediated decay of BOK mRNA in certain cancers, particularly in subtypes of kidney and lung carcinomas, considering their inverse correlation in the stratum of patients with the worst overall survival and/or risk of event. It should be noted, however, that, as a limitation of these results, such an inverse correlation was only shown at the mRNA level but not yet interrogated at the protein level. TRIM28 is increased in several cancerous malignancies, and increased TRIM28 is a poor prognosis factor in early-stage NSCLC (Liu et al., 2013) , glioma (Qi et al., 2016) , and colorectal cancer (Fitzgerald et al., 2013) . Furthermore, TRIM28 increases the expression of the ATP-binding cassette genes ABCG2 and ABCB1, thus contributing to chemoresistance to paclitaxel Figure 5 . Continued differences were detected using an unpaired t test, comparing with the BOK levels obtained on the sample transfected with the empty vector. Downregulation of BOK by overexpressed HA-TRIM28 correlates with reduced BOK mRNA levels (means GSD, N = 3).
(E) Stable expression of HA-tagged TRIM28 in the lung cancer cell lines NCI-H1299 and LFX-289 leads to a reduction of endogenous BOK levels. See Figure S3B for quantification. Significance levels, p < 0.01**, p < 0.001***, p < 0.0001****.
and cisplatin of epithelial ovarian cancer cells (Hu et al., 2015) . On the contrary, pro-apoptotic BOK is currently discussed as a potential tumor suppressor gene, since its genomic locus is deleted across various cancers (Beroukhim et al., 2010) and elevated levels of this protein are associated with enhanced overall survival of patients with lymph-node-positive lung cancer (Moravcikova et al., 2017) . It is currently not clear whether TRIM28-mediated repression of BOK levels primarily affects apoptotic responses or whether recently described ''non-apoptotic'' roles of BOK need to be considered as well (D'Orsi et al., 2016; Kalkat et al., 2013; Moravcikova et al., 2017; Rabachini et al., 2017) . Along that line, a molecular process potentially linking TRIM28 and BOK could be EMT. Knockdown of TRIM28 was shown to impair EMT in ovarian cancer cells by upregulation of E-cadherin (CHD1) and reduction of vimentin (VIM) and N-cadherin (CDH2) (Deng et al., 2017) . Along the same line, Chen and colleagues reported that, in NSCLCs, TGFb-induced EMT is dependent on induction of TRIM28, strongly suggesting that TRIM28 contributes to EMT in NSCLC (Chen et al., 2014) . TRIM28 was further shown to promote EMT and metastasis in breast cancer (Wei et al., 2016) . Strikingly these phenotypes reported for downregulation or overexpression of TRIM28 with regards to EMT are inversely mimicked by BOK, as we have recently shown for NSCLC cells that overexpression of BOK antagonizes TGFb-induced EMT (Moravcikova et al., 2017) , thereby further underlining the connection and opposing functions of TRIM28 and BOK in a cancer context.
In summary, we have identified a post-transcriptional negative regulation of BOK expression through association of TRIM28 with distinct URE present in the 3' UTR of the BOK transcript, resulting in destabilization and decay of the latter. This mechanism seems to rather specifically affect BOK, while sparing other pro-apoptotic multi-domain BCL-2 family members. Future efforts should focus on integrating this regulatory mechanism into the various (patho)physiological functions that have been described for BOK, in particular corroborating its relevance to cancer biology and its potential use by cancer cells to evade current chemotherapeutic regimens and/or to promote malignant transformation, including metastasis. . Potential Clinical Implications of the TRIM28 and BOK Interrelationship (A-C) (A) Multiparametric Cox hazard ratio modeling of BOK and TRIM28 mRNA levels in several cancer types. Number of patients (N), 95% confidence interval of the hazard ratio function (HR 95% CI), significance (p value), and overall significance of the model (Model p value) are tabulated. Patients were classified according to their BOK and TRIM28 levels with respect to each gene population median expression into two strata (''high''/''low'') and further analyzed for overall survival (B) and correlation of the two genes within each strata (C). Differences in survival were detected with the log rank test, and correlations were determined using the Spearman's estimate. Significance levels, p > 0.05 ns , p < 0.05*, p < 0.01**, p < 0.001***. See Table S2 for original and full data.
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Limitations of the Study
Recent advances in elucidating the role of BOK in health and disease suggest that its abundance could be a critical factor to the cellular fate. Nevertheless, we lack comprehensive understanding of how BOK levels are regulated. Our work provides another layer of BOK regulation, involving the description of destabilizing (AU/U)-rich elements in the 3' UTR of its mRNA. We currently do not know if and how strongly these regulatory elements contribute to physiology in development or in adult life. One of the destabilizing factors identified to associate with the U-rich elements of human BOK 3' UTR is TRIM28. It is not clear whether TRIM28 directly binds to mRNA or indirectly as part of a macromolecular protein complex and through which mechanism TRIM28 induces mRNA destabilization.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods, five figures, and two tables, and can be found with this article online at https://doi.org/10.1016/j.isci.2018.11.005.
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TRANSPARENT METHODS
Cell lines and cell culture
Dulbecco's Modified Eagle's Medium-high glucose (DMEM), RPMI 1640 AQmedia TM and 100 mM cell culture grade sodium pyruvate were purchased from Sigma-Aldrich Chemie GmbH (Buchs, CH); penicillin/streptomycin (P/S) and trypsin-EDTA were purchased from Gibco (Thermo Fisher Scientific Switzerland, Reinach, CH). Ultra-low endotoxin fetal calf serum (FCS) was purchased from Pan Biotech (Aidenbach, DE). SV40 LT-immortalized mouse embryo fibroblasts (SV40 MEF) derived from Bok --animals have been previously described (Echeverry et al., 2013) . The human embryonal kidney cell line containing the temperature sensitive mutant of the SV-40 large T-antigen (HEK293T) was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, DE). The non-small cell lung cancer cell line LXF-289 and the large-cell lung carcinoma cell line NCI-H1299 were obtained from the European Collection of Authenticated Cell Culture (ECACC, Salisbury, UK) and the DSMZ respectively. The colon colorectal carcinoma cell line HCT-116 was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Bok -/-SV40 MEF and HEK293T cells were cultured in DMEM supplemented with 1 mM sodium pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin and 5 % FCS while cancer cell lines were cultured in RPMI 1640 supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin and 10 % FCS. All cells were kept in a humidified incubator at 37°C with 5 % CO2. Human BOK cDNA harboring wildtype or URE mutated 3'UTR were cloned into pcDNA3.1 (see below), transfected into HEK293T cells and selected with 2.3 mg/mL G-418 (Gibco, Thermo Fisher Scientific Switzerland, Reinach, CH).
cDNA
Mouse Bok cDNA (ENSMUST00000027499.12, Cat#: MC206561, cloned into a pCMV6-Kan/Neo vector) was purchased from Origene (Rockville, MD, USA). Human BOK cDNA (ENST00000318407.4) was synthetized from isolated RNA derived from human immortalized hepatocytes (IHH cell line kindly provided by Prof. Thomas Brunner, University of Konstanz, DE). Briefly, 10 7 cells were collected washed with saline and the RNA extracted using the SV Total RNA extraction kit followed by reverse transcription of 1 µg of total RNA using the M-MLV reverse transcriptase according to the manufacturer's instructions (Promega, Dübendorf, CH). Human BOK cDNA was then amplified with the primers forward 5'-GTAGAATTCCTCGCTGCCCAGGCCCCCGACG-3' and reverse 5'-CATGCGGCCGCTCTGTCTAAAAT GACAACGA TCG-3' using the Phusion Hot Start Flex DNA Polymerase (New England Biolabs, Ipswich, MA, US), digested with EcoRI/NotI and cloned into the pcDNA3.1 vector.
